Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value: $167M (100.0% shares, 0.0% debt)

Holdings (36)

PRTA PROTHENA CORP PLC 13.0%
Value $21.79M Shares 441,000 Est. Cost $23.54 Unrealized +135.5%
GLPG GALAPAGOS NV 11.4%
Value $19.07M Shares 345,900 Est. Cost $58.27 Unrealized
ALBIREO PHARMA INC 7.2%
Value $11.97M Shares 514,082 Est. Cost $30.59 Unrealized
GALAPAGOS NV 6.6%
Value $11.04M Shares 200,300 Est. Cost Unrealized
CUE CUE BIOPHARMA INC 5.6%
Value $9.376M Shares 829,042 Est. Cost $15.21 Unrealized -15.3%
EHC ENCOMPASS HEALTH CORP 4.8%
Value $7.974M Shares 122,187 Est. Cost $49.64 Unrealized -0.4%
OSCR OSCAR HEALTH INC 4.3%
Value $7.261M Shares 925,000 Est. Cost $14.31 Unrealized -12.2%
CONVEY HEALTH SOLUTIONS HLDG 3.9%
Value $6.496M Shares 777,000 Est. Cost $9.97 Unrealized
KEZAR LIFE SCIENCES INC 3.6%
Value $6.019M Shares 360,000 Est. Cost $5.82 Unrealized
ZOGENIX INC 3.5%
Value $5.897M Shares 362,909 Est. Cost $18.57 Unrealized
CRL CHARLES RIV LABS INTL INC 3.5%
Value $5.833M Shares 15,481 Est. Cost $388.52 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 3.2%
Value $5.419M Shares 409,620 Est. Cost $21.26 Unrealized -25.1%
ALNY ALNYLAM PHARMACEUTICALS INC 3.2%
Value $5.411M Shares 31,907 Est. Cost $185.86 Unrealized 0.0%
ALDX ALDEYRA THERAPEUTICS INC 2.8%
Value $4.621M Shares 1,155,300 Est. Cost $7.86 Unrealized -2.9%
ARENA PHARMACEUTICALS INC 2.5%
Value $4.182M Shares 45,000 Est. Cost $50.17 Unrealized
AGL AGILON HEALTH INC 2.4%
Value $4.05M Shares 150,000 Est. Cost $31.52 Unrealized -22.8%
MORPHIC HLDG INC 2.1%
Value $3.454M Shares 72,898 Est. Cost $57.35 Unrealized
PRQR PROQR THRAPEUTICS N V 1.7%
Value $2.857M Shares 356,617 Est. Cost $5.23 Unrealized +45.5%
RCKT ROCKET PHARMACEUTICALS INC 1.7%
Value $2.81M Shares 128,705 Est. Cost $27.28 Unrealized 0.0%
PROTHENA CORP PLC 1.5%
Value $2.574M Shares 52,100 Est. Cost Unrealized
PROGYNY INC 1.5%
Value $2.518M Shares 50,000 Est. Cost Unrealized
STTK SHATTUCK LABS INC 1.3%
Value $2.215M Shares 260,243 Est. Cost $18.73 Unrealized -26.5%
CGTX COGNITION THERAPEUTICS INC 1.1%
Value $1.909M Shares 301,979 Est. Cost $9.75 Unrealized 0.0%
PANACEA ACQUISITION CORP II 1.1%
Value $1.9M Shares 195,855 Est. Cost $9.77 Unrealized
GMED GLOBUS MED INC 0.9%
Value $1.458M Shares 20,188 Est. Cost $72.59 Unrealized 0.0%
ACCOLADE INC 0.8%
Value $1.318M Shares 50,000 Est. Cost $42.17 Unrealized
CRSP CRISPR THERAPEUTICS AG 0.8%
Value $1.316M Shares 17,364 Est. Cost $87.36 Unrealized 0.0%
IOVA IOVANCE BIOTHERAPEUTICS INC 0.8%
Value $1.313M Shares 68,800 Est. Cost $24.79 Unrealized -11.2%
SIO GENE THERAPIES INC 0.6%
Value $1.035M Shares 802,180 Est. Cost $1.98 Unrealized
MRNA MODERNA INC 0.6%
Value $940K Shares 3,700 Est. Cost $292.38 Unrealized 0.0%
WEST PHARMACEUTICAL SVSC INC 0.4%
Value $704K Shares 1,500 Est. Cost Unrealized
CYMABAY THERAPEUTICS INC 0.3%
Value $564K Shares 166,775 Est. Cost $3.38 Unrealized
PRCT PROCEPT BIOROBOTICS CORP 0.3%
Value $500K Shares 20,000 Est. Cost $36.99 Unrealized 0.0%
EXICURE INC 0.3%
Value $490K Shares 2,426,508 Est. Cost $1.45 Unrealized
ODONATE THERAPEUTICS INC 0.2%
Value $404K Shares 298,900 Est. Cost $1.35 Unrealized
SPRY SILVERBACK THERAPEUTICS INC 0.2%
Value $358K Shares 53,815 Est. Cost $8.13 Unrealized 0.0%